Cypris Medical, Inc.’s Xact technology took home the “Best of Hot Topics” award at the American Society for Aesthetic Plastic Surgery (ASAPS) meeting in New York.

Xact technology is a minimally invasive face and neck lifting suturing device cleared by the US Food and Drug Administration in 2017.

“Our core technology, Xact, replaces two of the oldest technologies in surgery, the 100 year-old needle holder and the 70 year-old forceps,” says Cypris CEO Dan Holton in a news release. “The first target market is facial rejuvenation, including face and neck lifting. The unmet need is the lack of treatments available for patients who have exhausted benefits from facial injectables (‘filler fatigue’) but are not ready to make the jump to a full face lift.”

 “We project that Xact will be available to surgeons in Q4 of 2018,” says Holton. “Cadaver studies proved not only the safety of the procedure, but that we are mobilizing the same tissue as traditional face and neck lifting.” He adds that a series of 13 patients underwent the procedure and showed lasting results over two years. “On average, the procedure took 35 minutes per patient. No complications have been reported, and patients had very quick recovery time with high satisfaction,” says Holton. Other applications involve any procedure where a suture needs to be placed from a remote incision: breast lifting, breast reconstruction, body contouring and orthopedics.